#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Aspergillus infection Progressive supranuclear palsy Hereditary angioedema Anti-myelin-associated glycoprotein antibodies positive Von Willebrand's disease Prader-Willi syndrome Thrombotic microangiopathy Pneumonia Medullary thyroid cancer Acute myeloid leukaemia Alveolar proteinosis Biliary cancer metastatic Cryoglobulinaemia Chondrodystrophy More trials…

    Learn about Rare Diseases

    Proteus syndrome – Life with Disease Acquired haemophilia – Life with Disease Vascular malformation Alternating hemiplegia of childhood – Diagnostics Wolfram syndrome – Treatment Lysosomal storage disorder – Treatment Lymphatic malformation – Basic Information Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Niemann-Pick disease – Basic Information Breast angiosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nintedanib Sunitinib Afatinib Ripasudil Palivizumab Cabergoline Dapagliflozin Propanediol Pacritinib Relacorilant Phosphocreatine Sodium Pyridoxine Hydrochloride Folic Acid, Anhydrous Cefiderocol Umeclidinium Gallium (68Ga) Bisoprolol Fumarate Doconexent Nvl-655 Piracetam BROLUCIZUMAB More therapies…

    Learn about Your Condition

    Diabetic nephropathy Androgenetic alopecia Mucosal inflammation Richter's syndrome Hernia repair Vaginal infection Neurodevelopmental disorder Infective uveitis Lymphangiosarcoma Pancreatic neoplasm Paresis Spinal muscular atrophy Cytokine release syndrome Persistent depressive disorder Primary hyperthyroidism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rheumatoid arthritis

  • Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Baricitinib
    • Etanercept
    • Adalimumab
    Austria Belgium Czechia Denmark France Germany +9

  • A study comparing how ritlecitinib capsules work when sprinkled on food versus swallowed whole and with or without food in healthy adults

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Vitiligo
    • Alopecia areata
    • Rheumatoid arthritis
    Belgium

  • A study testing SPY072 compared to placebo in adults with moderately to severely active rheumatologic disease

    Not recruiting

    2 1
    Bulgaria Czechia Poland Spain

  • A study testing tulisokibart for people with rheumatoid arthritis who have not responded well enough to previous treatments

    Not recruiting

    2 1
    Investigated Drugs:
    • Tulisokibart
    Germany Poland Spain

  • Study of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Sar441566
    • Methotrexate
    Czechia Germany Greece Poland Slovakia Spain

  • Study of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Lutikizumab
    Czechia Germany Hungary Poland Slovakia Spain
Previous Page
1 … 6 7 8 9 10 … 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!